JOHNSON & JOHNSON |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,645 MXN | +0.53% |
|
-1.37% | -0.03% |
| 07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
| 07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
42849d93cf5e255.zusGTY_YGwKhmN2nKTPAKrmITipyzLDv-WPrW3-YEx4.rdlXGb2sfUnUy579Q3S5QYDDKlAi_9q_si6FFi_tJSq2uTF8xOAsWNvanA~ad2723680f616ffaa4cd911017ec264a
